Valuation: Feedback plc

Market Cap 2.69M 3.6M 3.16M 2.94M 5.06M 346M 5.14M 34.87M 13.62M 170M 13.5M 13.21M 589M P/E 2026 *
-
P/E 2027 * -
Enterprise Value 713K 951K 836K 777K 1.34M 91.62M 1.36M 9.23M 3.61M 45.04M 3.57M 3.49M 156M EV / Sales 2026 *
0.88x
EV / Sales 2027 * 4.46x
Free-Float
94.51%
Yield 2026 *
-
Yield 2027 * -
1 week-0.81%
Current month-13.38%
1 month-13.38%
3 months-36.92%
6 months-45.33%
Current year-36.10%
1 week 6.12
Extreme 6.125
6.3
1 month 6.1
Extreme 6.1
7.2
Current year 6.1
Extreme 6.1
15
1 year 6.1
Extreme 6.1
15
3 years 6.1
Extreme 6.1
152.92
5 years 6.1
Extreme 6.1
274.8
10 years 6.1
Extreme 6.1
1,040
Manager TitleAgeSince
Chief Executive Officer 38 09/04/2019
Director of Finance/CFO 54 10/11/2025
Compliance Officer 56 01/02/2001
Director TitleAgeSince
Director/Board Member 38 09/04/2019
Chairman 72 18/11/2019
Director/Board Member 55 03/02/2020
Date Insider Type Main position Quantity % Market Cap.
23/12/25 Buy

Chief Financial Officer

60,549 0.1382%
23/12/25 Buy

Chief Executive Officer

60,904 0.1390%
10/7/25 Free

Public Communications Manager

219,073 0.5000%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.81%-57.59%-93.35% 3.6M
+3.71%-4.68%-36.05%-5.45% 30.25B
-1.42%-14.59%-50.04%+138.50% 11.68B
+1.76%-3.42%-27.38%+57.74% 5.28B
-1.99%-3.05% - - 2.08B
+2.86%-10.62%+45.75%-34.09% 1.86B
-3.11%-1.18% - - 1.72B
-3.12%-3.55%-39.08% - 1.03B
-2.01%-3.95%+35.19%+102.78% 865M
-4.53%-4.82%-44.46%-57.70% 723M
Average -0.79%-5.12%-21.71%+15.49% 5.55B
Weighted average by Cap. +1.67%-6.65%-34.36%+34.35%

Financials

2026 *2027 *
Net sales 810K 1.08M 949K 883K 1.52M 104M 1.55M 10.48M 4.1M 51.17M 4.06M 3.97M 177M 810K 1.08M 949K 883K 1.52M 104M 1.55M 10.48M 4.1M 51.17M 4.06M 3.97M 177M
Net income - -
Net Debt -1.98M -2.64M -2.32M -2.16M -3.72M -255M -3.78M -25.64M -10.02M -125M -9.92M -9.71M -433M 914K 1.22M 1.07M 996K 1.72M 117M 1.74M 11.83M 4.62M 57.74M 4.58M 4.48M 200M
Logo Feedback plc
Feedback plc is a United Kingdom-based clinical infrastructure specialist. The Company designs products that enhance clinician access to patient data and to their colleagues. The Company's approach centers around individual patient episodes, into which it pulls relevant clinical data from hospital systems and around which it builds remote clinical teams for collaboration. The Company’s segments include Medical Imaging and Feedback Medical Imaging India. Its products include Bleepa and CareLocker. Bleepa is its application layer and sits on top of CareLocker as its data layer. Bleepa is its communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multidisciplinary team working and diagnostic-enhanced advice and guidance. CareLocker is its patient-facing platform that gives patients access and control over their diagnostic and other clinical data.
Employees
29
Date Price Change Volume
24/07/26 GBX 6.150 0.00% 40,000
23/07/26 GBX 6.150 -1.60% 50,159
22/07/26 GBX 6.250 -0.79% 20,111
21/07/26 GBX 6.300 +1.61% 23,773
20/07/26 GBX 6.200 0.00% 94,572
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0615GBP
Average target price
0.6000GBP
Spread / Average Target
+875.61%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FDBK Stock